Redefining early stage nonsmall cell lung cancer: The dawn of the risk‐adaptive and biologically precise era
Clarissa Mathias, Fabio Ynoe Moraes · 2026
Read Redefining early stage nonsmall cell lung cancer: The dawn of the risk‐adaptive and biologically precise era by Clarissa Mathias, Fabio Ynoe Moraes (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13555831.txt.
Description
Clarissa Mathias and Fabio Moraes argue that early lung cancer care is shifting from size charts to biology, in a 2026 commentary. For decades, early non-small cell lung cancer was staged by anatomy and treated mainly with surgery. That simple scheme helped many patients but ignores how differently tumors behave.
Screening advances, gentler surgery, precise radiation, gene profiling, and drug therapy around surgery have changed the field together. Care can now adapt to a tumor’s recurrence risk and molecular traits, not just its size and spread. Discussing a recent review by Zhang and colleagues, the authors map the new era of risk-adaptive, biologically precise care. Patients with the same stage may rightly receive quite different plans.
Catalog record
| CREATOR | Clarissa Mathias, Fabio Ynoe Moraes |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 12 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |